Vikram, Hemanth P. R.Kumar, Tegginamath PramodKumar, GunjanBeeraka, Narasimha M.Deka, RajashreeSuhail, Sheik MohammedJat, SandeepBannimath, NamithaPadmanabhan, GayatiriChandan, Ravandur S.Kumar, PramodGurupadayya, Bannimath2024-09-172024-09-172024Vikram HPR, Kumar TP, Kumar G, et al. Corrigendum to "Nitrosamines crisis in pharmaceuticals - Insights on toxicological implications, root causes and risk assessment: A systematic review" [J. Pharm. Anal. 14 (2024) 100919]. J Pharm Anal. 2024;14(6):101033. doi:10.1016/j.jpha.2024.101033https://hdl.handle.net/1805/43358[This corrects the article DOI: 10.1016/j.jpha.2023.12.009.].en-USAttribution 4.0 InternationalCarcinogenicityGenotoxicityMutagenicityMolecular toxicityNitrosamine impuritiesNitrosamine drug substance-related impuritiesArticle